Quantitative Prediction of the Effect of CYP3A Inhibitors and Inducers on Venetoclax Pharmacokinetics Using a Physiologically Based Pharmacokinetic Model.
about
Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma.Moving Beyond Maximum Tolerated Dose for Targeted Oncology Drugs: Use of Clinical Utility Index to Optimize Venetoclax Dosage in Multiple Myeloma Patients.Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling.Clinical evaluation of P-glycoprotein inhibition by venetoclax: a drug interaction study with digoxin.Pharmacokinetics of the BCL-2 Inhibitor Venetoclax in Healthy Chinese Subjects.Exposure-response evaluations of venetoclax efficacy and safety in patients with non-Hodgkin lymphoma.Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact.Guiding dose adjustment of amlodipine after co-administration with ritonavir containing regimens using a physiologically-based pharmacokinetic/pharmacodynamic model.Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics.
P2860
Q39177442-C7A4EB1D-A730-4887-A09C-4166A1B14415Q45057327-74E655DA-BB0B-4DAC-B94E-8FA0BECFA58EQ47592224-C45DED87-34F4-42B3-A8D8-9DABB8C0E145Q47610956-DFC85F9C-6766-4D5C-8BA9-08CDF45D0D1BQ48146110-46761719-E66E-427A-99B7-A905238B7D44Q48257454-2947F57C-FD6A-4977-807C-CF288346162DQ49171317-BD102876-3FD2-4BF4-BA2A-FC2995F1A40CQ50050263-4D1430D0-F242-4740-B7A3-D4A05F7CB848Q50119590-1CD4B29E-2FD6-4774-B7BD-AC4A32BDD437
P2860
Quantitative Prediction of the Effect of CYP3A Inhibitors and Inducers on Venetoclax Pharmacokinetics Using a Physiologically Based Pharmacokinetic Model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Quantitative Prediction of the ...... y Based Pharmacokinetic Model.
@en
Quantitative Prediction of the ...... y Based Pharmacokinetic Model.
@nl
type
label
Quantitative Prediction of the ...... y Based Pharmacokinetic Model.
@en
Quantitative Prediction of the ...... y Based Pharmacokinetic Model.
@nl
prefLabel
Quantitative Prediction of the ...... y Based Pharmacokinetic Model.
@en
Quantitative Prediction of the ...... y Based Pharmacokinetic Model.
@nl
P2860
P356
P1476
Quantitative Prediction of the ...... y Based Pharmacokinetic Model.
@en
P2093
Ahmed Hamed Salem
Kevin J Freise
P2860
P304
P356
10.1002/JCPH.858
P577
2017-01-04T00:00:00Z